Generate a tailored SOP for Dr. Xianxin Hua. Improve your application with a focused, well-structured draft.
Xianxin Hua is a Professor in the Department of Cancer Biology at the University of Pennsylvania's Perelman School of Medicine. He holds an M.D. from Hubei Medical College and a Ph.D. in Cell Regulation from the University of Texas Southwestern Medical Center. His research focuses on the molecular mechanisms involving Menin, a tumor suppressor protein, its role in regulating gene transcription, and its implications in cancer biology, particularly in neuroendocrine tumors (NETs), colorectal cancer (CRC), and acute myeloid leukemia (AML). Hua's work aims to develop innovative immunotherapeutic strategies such as Chimeric Antigen Receptor (CAR) T cells, targeting specific tumor-associated antigens (TAAs). He established the Sequential Tumor-selected Antibody antigen-Retrieval (STAR) platform to isolate nanobodies selective for NETs and AML, paving the way for new therapeutic approaches. Hua employs a diverse range of methodologies, including protein engineering, synthetic biology, bioinformatics, and gene editing, to uncover the complex interactions of epigenetic regulators in cancer pathology.
Wharton Doctoral programs cover fields like Finance, Marketing, Management, and Operations, Information and Decisions.